.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Accenture
Colorcon
Harvard Business School
Baxter
Cantor Fitzgerald
Fish and Richardson
Novartis
Express Scripts
Mallinckrodt

Generated: December 16, 2017

DrugPatentWatch Database Preview

Trandolapril; verapamil hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for trandolapril; verapamil hydrochloride and what is the scope of trandolapril; verapamil hydrochloride freedom to operate?

Trandolapril; verapamil hydrochloride
is the generic ingredient in two branded drugs marketed by Abbvie and Glenmark Generics, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for trandolapril; verapamil hydrochloride. Four suppliers are listed for this compound.

Summary for trandolapril; verapamil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glenmark GenericsTRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDEtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL079135-003May 5, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsTRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDEtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL079135-002May 26, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsTRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDEtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL079135-001May 26, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Glenmark GenericsTRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDEtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL079135-004Aug 30, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-004Oct 22, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996ABRXYesNo► Subscribe► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: trandolapril; verapamil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-002Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-004Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-004Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-001Oct 22, 1996► Subscribe► Subscribe
AbbvieTARKAtrandolapril; verapamil hydrochlorideTABLET, EXTENDED RELEASE;ORAL020591-003Oct 22, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Healthtrust
Colorcon
Deloitte
Covington
Chubb
Cerilliant
Fish and Richardson
Farmers Insurance
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot